Indian manufacture of new generic antiretrovirals: implications for global access to anti-HIV drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Indian manufacture of new generic antiretrovirals: implications for global access to anti-HIV drugs

Published:2010-01 Issue:1 Volume:4 Page:1-4
ISSN:1758-4310
Container-title:HIV Therapy
language:en
Short-container-title:HIV Therapy

Author:

Venkatesh Kartik K¹,Kumarasamy Nagalingeswaran²,Mayer Kenneth H³

Affiliation:

1. Departments of Medicine & Community Health, Miriam Hospital/Brown University, Providence, RI, USA

2. YR Gaitonde Centre for AIDS Research & Education, Voluntary Health Services, Chennai, India

3. Departments of Medicine & Community Health, Miriam Hospital/Brown University, Providence, RI, USA.

Publisher

Future Medicine Ltd

Subject

Pharmacology (medical),Infectious Diseases,Virology,Dermatology,Drug Discovery,Pharmacology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/hiv.09.55

Reference19 articles.

1. Majumdar B: India patent rejections welcomed by HIV/AIDS groups.Reuters, 9 September (2009).

2. ButlerD: India says no to HIV drug patents: patent office rejects applications from two US drug companies.Nat. News, 3 September (2009).

3. HIV drug policies and South markets: settling controversies

4. Patents versus Patients? Antiretroviral Therapy in India

5. HIV epidemiology and the effects of antiviral therapy on long-term consequences

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-1 Is Associated With Lower Group BStreptococcusCapsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women;Journal of Infectious Diseases;2015-02-04

2. Low-Cost Generic Drugs Under The President’s Emergency Plan For AIDS Relief Drove Down Treatment Cost; More Are Needed;Health Affairs;2012-07

3. How HIV treatment could result in effective prevention;Future Virology;2010-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3